DEERFIELD, Ill. — On the eve of a potential Federal Trade Commission approval of the Express Scripts/Medco merger, Walgreens' underlying fundamentals still are strong, Walgreens president and CEO Greg Wasson told analysts Tuesday morning. It's that underlying strength that has helped Walgreens in the wake of its exit from the Express Scripts pharmacy benefit network, a factor that impacted Walgreens' net earnings by 7 cents per diluted share for its second quarter ended Feb. 29. Net earnings for the second quarter were $683 million, a 7.7% decrease.
